Cell Therapy Packaging Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed
The Cell Therapy Packaging Market is valued at USD 361 million in 2024 growing at a CAGR of 11.8% during the forecast period 2024-2035.
Cell therapy involves utilizing a patient's own cells (autologous) or cells from a healthy donor (allogeneic), which are genetically re-programmed to combat various diseases. Patients receive injections of viable cells that are expected to provide therapeutic benefits. Notably, cell and gene therapies have been employed to address a spectrum of rare and genetic medical conditions, including cancer, arthritis, dementia, leukemia, and others that pose significant treatment challenges. Presently, over 30 cell and gene therapies have gained FDA approvals, with numerous therapeutic candidates advancing through clinical development stages. In recent years, cell therapy has garnered substantial attention from healthcare industry stakeholders due to its immense potential in treating rare disorders, supported by a robust body of clinical evidence demonstrating its therapeutic benefits and potential.
The success of cell therapies hinges on the safe and timely delivery of viable therapeutic cell doses to the appropriate patients. Additionally, maintaining specific temperature conditions (depending on the therapy) throughout the supply chain is crucial to preserving the stability and integrity of cell therapy drug products. These therapies undergo stringent regulatory scrutiny at each manufacturing step to ensure packaging product quality standards are met. Given the complexities involved in the cell therapy packaging realm, numerous drug developers are opting to outsource their packaging needs to Contract Research Organizations (CROs). Driven by the increasing demand for cell-based therapeutics, the market for cell therapy packaging services is poised to witness significant growth in the forecast period.
Key Market Segments
Type of Therapy Packed
T-cell Therapies
Dendritic Cell Vaccines
Stem Cell Therapies
NK-cell Therapies
Other Advanced Therapy Medicinal Products
Scale of Operations
Clinical Scale
Commercial Scale
Package Engineering Design
Primary Packaging
Secondary Packaging
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
Research Coverage:
Comprehensive overview of current market landscape of cell therapy packaging services providers, including a detailed analysis based on their year of establishment, company size, location of headquarters, type of services offered (packaging, distribution, storage, labeling, manufacturing, management solutions, drug return & destruction, serialization, analytical and other services), type of packaging (active and passive packaging), type of passive system offered (dry shippers and VIP insulations), packaging engineering design (primary and secondary packaging), phase change material used (dry ice and liquid nitrogen).
A detailed analysis of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bag, vial, shipping container and others), type of container fabrication material (plastic and others), raw materials for container fabrication (ethylene vinyl acetate (EVA), insulated panel, polypropylene, fluorinated ethylene propylene, USP class VI materials, polyethylene and others), type of cells packed (blood cells, hematopoietic cells, lymphocytes, stem cells, mesenchymal cells, cord blood cells, induced pluripotent cells and chondrocytes), storage conditions (ambient, refrigerated, freezing and cryogenic temperatures), and usability of container (single-use and multiple-use products). Further, the product providers have also been analyzed on the basis of parameters, such as their year of establishment, company size, location of headquarters and most active players (in terms of number of products).
Detailed company profiles of key players (shortlisted based on a proprietary criterion) in offering cell therapy packaging products and services. Each profile features a brief overview of the company, details related to its service portfolio / product portfolio, recent developments and an informed future outlook.
An in-depth competitiveness assessment of cell therapy packaging service providers based across different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported), service portfolio (type of additional services offered).
Comprehensive assessment of the different partnerships established between cell therapy packaging providers and cell therapy developers, during the period 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service offered, and geographical location of players involved in the partnership.
A list of over 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).
A case study highlighting the players, claiming to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.
Comprehensive cell therapy packaging market forecast to estimate the current market size and future opportunity over the next 11 years. Based on multiple parameters, likely adoption of cell therapy packaging products and services and through secondary sources, we have provided an informed estimate on the market size during the forecast period 2024-2035.
Comprehensive projections of the current and future opportunity within the cell therapy packaging market across different type of therapies packed, such as T-cell therapies, dendritic cell vaccines, stem cell therapies, NK-cell therapies and other advanced therapy medicinal products.
Detailed predictions of the current and future opportunity within the cell therapy packaging market based on different scales of operations, such as clinical and commercial.
Comprehensive predictions of the current and future cell therapy packaging market based on different package engineering designs, such as primary packaging and secondary packaging.
Detailed predictions of the current and future opportunity within the cell therapy packaging market based on key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Cell Therapy Packaging Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
Almac
Catalent Biologics
Cryoport Systems
Saint-Gobain
Thermo Fisher Scientific
West Pharmaceuticals
Yourway
- 1. Preface
- 1.1. Scope Of The Report
- 1.2. Research Methodology
- 1.3. Key Questions Answered
- 1.4. Chapter Outlines
- 2. Executive Summary
- 3. Introduction
- 3.1. Chapter Overview
- 3.2. Pharmaceutical Filling And Packaging
- 3.3. Importance Of Pharmaceutical Packaging
- 3.4. Types Of Pharmaceutical Packaging
- 3.5. Packaging Of Cell Therapies
- 3.5.1. Primary Packaging
- 3.5.2. Secondary Packaging
- 3.6. Cell Therapy Packaging: Key Considerations
- 3.7. Challenges Associated With Cell Therapy Packaging
- 3.8. Concluding Remarks
- 4. Cell Therapy Packaging Service Providers: Market Landscape
- 4.1. Chapter Overview
- 4.2. Cell Therapy Packaging Service Providers: Overall Market Landscape
- 4.2.1. Analysis By Year Of Establishment
- 4.2.2. Analysis By Company Size
- 4.2.3. Analysis By Location Of Headquarters
- 4.2.4. Analysis By Services Offered
- 4.2.5. Analysis By Type Of Packaging
- 4.2.6. Analysis By Type Of Passive System Offered
- 4.2.7. Analysis By Type Of Package Engineering Design
- 4.2.8. Analysis By Phase Change Material Used
- 4.2.9. Analysis By Temperature Ranges Supported
- 4.2.10. Analysis By Type Of Cells Handled
- 5. Cell Therapy Packaging Product Providers: Market Landscape
- 5.1. Chapter Overview
- 5.2. Cell Therapy Packaging Products: Market Landscape
- 5.2.1. Analysis By Type Of Packaging Container
- 5.2.2. Analysis By Container Fabrication Material And Raw Materials For Container Fabrication
- 5.2.3. Analysis By Type Of Cells Packed
- 5.2.4. Analysis By Storage Conditions
- 5.2.5. Analysis By Usability Of Container
- 5.3. Cell Therapy Packaging: Product Providers Landscape
- 5.3.1. Analysis By Year Of Establishment
- 5.3.2. Analysis By Company Size
- 5.3.3. Analysis By Location Of Headquarters
- 5.3.4. Most Active Players: Distribution By Number Of Products
- 6. Cell Therapy Packaging Service And Product Providers: Company Profiles
- 6.1. Chapter Overview
- 6.2 Cell Therapy Packaging Service Providers
- 6.2.1. Almac
- 6.2.1.1. Company Overview
- 6.2.1.2. Cell Therapy Service Portfolio
- 6.2.1.3. Recent Developments And Future Outlook
- 6.2.2. Catalent Biologics
- 6.2.2.1. Company Overview
- 6.2.2.2. Cell Therapy Service Portfolio
- 6.2.2.3. Recent Developments And Future Outlook
- 6.2.3. Cryoport Systems
- 6.2.3.1. Company Overview
- 6.2.3.2. Cell Therapy Service Portfolio
- 6.2.3.3. Recent Developments And Future Outlook
- 6.2.4. Yourway
- 6.2.4.1. Company Overview
- 6.2.4.2. Cell Therapy Service Portfolio
- 6.2.4.3. Recent Developments And Future Outlook
- 6.3. Cell Therapy Packaging Product Providers
- 6.3.1. Saint-gobain Life Sciences
- 6.3.1.1. Company Overview
- 6.3.1.2. Cell Therapy Packaging Product Portfolio
- 6.3.1.3. Recent Developments And Future Outlook
- 6.3.2. Thermo Fisher Scientific
- 6.3.2.1. Company Overview
- 6.3.2.2. Cell Therapy Packaging Product Portfolio
- 6.3.2.3. Recent Developments And Future Outlook
- 6.3.3. West Pharmaceutical Services
- 6.3.3.1. Company Overview
- 6.3.3.2. Cell Therapy Packaging Product Portfolio
- 6.3.3.3. Recent Developments And Future Outlook
- 7. Company Competitiveness Analysis
- 7.1. Chapter Overview
- 7.2. Key Parameters
- 7.3. Methodology
- 7.4. Cell Therapy Packaging Service Providers: Company Competitiveness Analysis
- 7.4.1. Companies Based In North America
- 7.4.2. Companies Based In Europe And Asia-pacific
- 8. Partnerships And Collaborations
- 8.1. Chapter Overview
- 8.2. Partnership Models
- 8.3. Cell Therapy Packaging: List Of Partnerships And Collaborations
- 8.3.1. Analysis By Year Of Partnership
- 8.3.2. Analysis By Type Of Partnership
- 8.3.3. Analysis By Year And Type Of Partnership
- 8.3.4. Analysis By Purpose Of Partnership
- 8.3.5. Analysis By Type Of Service(S) Covered
- 8.3.6. Most Active Players: Analysis By Number Of Partnerships
- 8.3.7. Regional Analysis
- 8.3.8. Intercontinental And Intracontinental Agreements
- 9. Likely Partner Analysis
- 9.1. Chapter Overview
- 9.2. Scope And Methodology
- 9.3. Potential Strategic Partners For Cell Therapy Packaging Providers In North America
- 9.3.1. Most Likely Partners
- 9.3.2. Likely Partners
- 9.3.3. Less Likely Partners
- 9.4. Potential Strategic Partners For Cell Therapy Packaging Providers In Europe
- 9.4.1. Most Likely Partners
- 9.4.2. Likely Partners
- 9.4.3. Less Likely Partners
- 9.5. Potential Strategic Partners For Cell Therapy Packaging Providers In Asia Pacific And Rest Of The World
- 9.5.1. Most Likely Partners
- 9.5.2. Likely Partners
- 9.5.3. Less Likely Partners
- 10. Cell Therapy Developers And Manufacturers: Case Study
- 10.1. Chapter Overview
- 10.2. Cell Therapy Manufacturers: Overall Market Landscape
- 10.2.1. Analysis By Year Of Establishment
- 10.2.2. Analysis By Company Size
- 10.2.3. Analysis By Location Of Headquarters
- 10.2.4. Analysis By Location Of Manufacturing Facility
- 10.2.5. Analysis By Type Of Cell(S) Manufactured
- 10.2.6. Analysis By Source Of Cells
- 10.2.7. Analysis By Scale Of Operation
- 10.2.8. Analysis By Manufacturing Capabilities / Services
- 10.2.9. Concluding Remarks
- 11. Global Cell Therapy Packaging Market
- 11.1. Chapter Overview
- 11.2. Assumptions And Methodology
- 11.3. Global Cell Therapy Packaging Services Market, Forecasted Estimates (2024-2035)
- 11.4. Scenario Analysis
- 11.4.1. Conservative Scenario
- 11.4.2. Optimistic Scenario
- 11.5. Key Market Segmentations
- 12. Cell Therapy Packaging Market, By Type Of Therapy
- 12.1. Chapter Overview
- 12.2. Key Assumptions And Methodology
- 12.3. Cell Therapy Packaging Market: Distribution By Type Of Therapy
- 12.3.1. T-cell Therapies Packaging: Forecasted Estimates (2024-2035)
- 12.3.2. Dendritic Cell Vaccines Packaging: Forecasted Estimates (2024-2035)
- 12.3.3. Stem Cell Therapies Packaging: Forecasted Estimates (2024-2035)
- 12.3.4. Nk-cell Therapies Packaging: Forecasted Estimates (2024-2035)
- 12.3.5. Other Advanced Therapy Medicinal Products Packaging: Forecasted Estimates (2024-2035)
- 12.4. Data Triangulation And Validation
- 13. Cell Therapy Packaging Market, By Scale Of Operation
- 13.1. Chapter Overview
- 13.2. Key Assumptions And Methodology
- 13.3. Cell Therapy Packaging Market: Distribution By Scale Of Operation
- 13.3.1. Clinical Scale: Forecasted Estimates (2024-2035)
- 13.3.2. Commercial Scale: Forecasted Estimates (2024-2035)
- 13.4. Data Triangulation And Validation
- 14. Cell Therapy Packaging Market, By Package Engineering Design
- 14.1. Chapter Overview
- 14.2. Key Assumptions And Methodology
- 14.3. Cell Therapy Packaging Market: Distribution By Package Engineering Design
- 14.3.1. Primary Packaging: Forecasted Estimates (2024-2035)
- 14.3.2. Secondary Packaging: Forecasted Estimates (2024-2035)
- 14.4. Data Triangulation And Validation
- 15. Cell Therapy Packaging Market, By Key Geographical Regions
- 15.1. Chapter Overview
- 15.2. Key Assumptions And Methodology
- 15.3. Cell Therapy Packaging Market: Distribution By Key Geographical Regions
- 15.3.1. North America: Forecasted Estimates (2024-2035)
- 15.3.2. Europe: Forecasted Estimates (2024-2035)
- 15.3.3. Asia-pacific: Forecasted Estimates (2024-2035)
- 15.3.4. Rest Of The World: Forecasted Estimates (2024-2035)
- 15.4. Data Triangulation And Validation
- 16. Concluding Remarks
- 16.1. Chapter Overview
- 17. Appendix 1: Tabulated Data
- 18. Appendix 2: List Of Companies And Organizations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook